REGENXBIO Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.04 |
Market Cap |
$1.74 B |
Shares Outstanding |
36.64 M |
Public Float |
33.62 M |
Address |
9600 Blackwell Road Rockville Maryland 20850 United States |
Employees | - |
Website | http://www.regenxbio.com |
Updated | 07/08/2019 |
REGENXBIO, Inc. is a biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. The company was founded by Kennth T. Mills and James M. |